NBIX
Neurocrine Biosciences Inc
Price:  
139.40 
USD
Volume:  
423,835.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NBIX WACC - Weighted Average Cost of Capital

The WACC of Neurocrine Biosciences Inc (NBIX) is 8.1%.

The Cost of Equity of Neurocrine Biosciences Inc (NBIX) is 8.15%.
The Cost of Debt of Neurocrine Biosciences Inc (NBIX) is 4.30%.

Range Selected
Cost of equity 6.80% - 9.50% 8.15%
Tax rate 23.10% - 26.00% 24.55%
Cost of debt 4.00% - 4.60% 4.30%
WACC 6.7% - 9.5% 8.1%
WACC

NBIX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.63 0.83
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 9.50%
Tax rate 23.10% 26.00%
Debt/Equity ratio 0.01 0.01
Cost of debt 4.00% 4.60%
After-tax WACC 6.7% 9.5%
Selected WACC 8.1%